Gordon Ramsay's fiery rejection of weight-loss drug menus
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.